Scilex Holding Co current report, 06 December 2021

Scilex Holding Co. — Form 8-K Summary

Business Context and Reporting Period

Vickers Vantage Corp. I, a Cayman Islands special purpose acquisition company, filed a Form 8-K dated December 6, 2021. The filing announced the signing of a letter of intent for a potential business combination with Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc.

Financial Metrics and Liquidity

The filing does not provide revenue, earnings, cash flow, margins, debt, liquidity, valuation, transaction consideration, or other operating and financial metrics for Scilex or Vickers Vantage Corp. I.

Material Changes Versus Prior Period

No period-over-period financial information or comparable-period results are included. The material development is the execution of a non-binding letter of intent for a potential business combination.

Guidance, Outlook, Risks, and Unusual Items

  • The letter of intent concerns a potential transaction; the filing does not state that a definitive agreement has been executed or that the transaction will close.
  • The filing text does not provide transaction structure, purchase price, ownership percentages, financing terms, expected closing date, or required approvals.
  • The press release is furnished as Exhibit 99.1 and is not deemed filed for purposes of Section 18 of the Exchange Act, except as expressly incorporated by reference.
  • No management financial guidance, detailed outlook, risk factors, contingencies, or unusual accounting items are provided in the filing text.

Key Facts Investors Should Verify

  • Whether the letter of intent resulted in a definitive merger or business combination agreement.
  • The proposed valuation, consideration, capitalization, pro forma ownership, and financing arrangements.
  • Scilex’s historical and projected revenue, profitability, cash flow, debt, and liquidity.
  • Required shareholder, regulatory, exchange, and other approvals and the expected transaction timeline.
  • The full contents of Exhibit 99.1, which may contain additional transaction terms and forward-looking statements.